UOC
KLRS

UBS O'Connor’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

UBS O'Connor’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,000
Closed -$495K – 559
2023
Q3 		$495K Buy
10,000
+2,609
+35% +$129K 0.01% 385
2023
Q2 		$578K Buy
+7,391
New +$578K 0.01% 423